These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24030889)

  • 1. Authors' redress on 'robustness of methods for blinded sample size re-estimation with overdispersed count data'.
    Cook RJ
    Stat Med; 2013 Sep; 32(22):3955-7. PubMed ID: 24030889
    [No Abstract]   [Full Text] [Related]  

  • 2. Robustness of methods for blinded sample size re-estimation with overdispersed count data.
    Schneider S; Schmidli H; Friede T
    Stat Med; 2013 Sep; 32(21):3623-35. PubMed ID: 23595966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blinded sample size re-estimation in superiority and noninferiority trials: bias versus variance in variance estimation.
    Friede T; Kieser M
    Pharm Stat; 2013; 12(3):141-6. PubMed ID: 23509095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size re-estimation in a breast cancer trial.
    Hade EM; Jarjoura D; Lai Wei
    Clin Trials; 2010 Jun; 7(3):219-26. PubMed ID: 20392786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size calculator for cluster randomized trials.
    Campbell MK; Thomson S; Ramsay CR; MacLennan GS; Grimshaw JM
    Comput Biol Med; 2004 Mar; 34(2):113-25. PubMed ID: 14972631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blinded sample size re-estimation for comparing over-dispersed count data incorporating follow-up lengths.
    Igeta M; Matsui S
    Stat Med; 2022 Dec; 41(29):5622-5644. PubMed ID: 36148560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-estimating the sample size of an on-going blinded trial based on the method of randomization block sums.
    Ganju J; Xing B
    Stat Med; 2009 Jan; 28(1):24-38. PubMed ID: 18837073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discussion of "Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data".
    Small DS; Cheng J
    Biometrics; 2009 Sep; 65(3):682-6; discussion 689-91. PubMed ID: 18759846
    [No Abstract]   [Full Text] [Related]  

  • 9. Blinded and unblinded internal pilot study designs for clinical trials with count data.
    Schneider S; Schmidli H; Friede T
    Biom J; 2013 Jul; 55(4):617-33. PubMed ID: 23703749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing the sample size during clinical trials with t-distributed test statistics without inflating the type I error rate.
    Timmesfeld N; Schäfer H; Müller HH
    Stat Med; 2007 May; 26(12):2449-64. PubMed ID: 17080491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should minimization replace randomization in all clinical trials?
    Tugwell P; Knottnerus JA; Idzerda L
    J Clin Epidemiol; 2012 Jan; 65(1):1-2. PubMed ID: 22083018
    [No Abstract]   [Full Text] [Related]  

  • 12. Sample size for a two-group comparison of repeated binary measurements using GEE.
    Jung SH; Ahn CW
    Stat Med; 2005 Sep; 24(17):2583-96. PubMed ID: 16118812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bayesian adaptive blinded sample size adjustment method for risk differences.
    Hartley AM
    Pharm Stat; 2015; 14(6):488-514. PubMed ID: 26403845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concerning: 'The number needed to treat needs an associated odds estimation'.
    Alderson P; Deeks JJ
    J Public Health (Oxf); 2004 Dec; 26(4):400; author reply 401. PubMed ID: 15598862
    [No Abstract]   [Full Text] [Related]  

  • 15. On the inappropriateness of an EM algorithm based procedure for blinded sample size re-estimation by T. Friede and M. Kieser, Statistics in Medicine 2002; 21:165-176.
    Gould AL; Shih WJ
    Stat Med; 2005 Jan; 24(1):147-54; author reply154-6. PubMed ID: 15619269
    [No Abstract]   [Full Text] [Related]  

  • 16. Blinded sample size recalculation in clinical trials incorporating historical data.
    Hees K; Kieser M
    Contemp Clin Trials; 2017 Dec; 63():2-7. PubMed ID: 28735110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
    Mütze T; Friede T
    Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discussions.
    Vansteelandt S
    Biometrics; 2009 Sep; 65(3):686-9; discussion 689-91. PubMed ID: 18759845
    [No Abstract]   [Full Text] [Related]  

  • 19. A post hoc evaluation of a sample size re-estimation in the Secondary Prevention of Small Subcortical Strokes study.
    McClure LA; Szychowski JM; Benavente O; Hart RG; Coffey CS
    Clin Trials; 2016 Oct; 13(5):537-44. PubMed ID: 27094488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and semiparametric analysis of non-inferiority trials with active and placebo control for censored time-to-event data.
    Kombrink K; Munk A; Friede T
    Stat Med; 2013 Aug; 32(18):3055-66. PubMed ID: 23508697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.